Total Visits

Views
Comparison of stem cell signaling pathways in long-term responders (LR) versus primary refractory (PR) patients with metastatic clear-cell renal cell carcinoma (ccRCC) under sunitinib (SU) treatment (SULONG study)19

Select a period of time:

Views

Views
May 20243
June 20241
July 20240
August 20245
September 20247
October 20240
November 20240
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States13
 

Top cities views

Views
Chicago5
Fort Worth1